Open Pharma blockchain cdc healthcare header

Open technologies and real-time collaboration for life sciences.

Modern, interoperable and usable technologies for today's healthcare and life sciences.

OpenPharma offers native applications—built by us, marketplace offerings—built by our partners, and the plumbing to build new innovations and custom solutions for our clients.

Open Pharma Application Programming Interface icon
Interoperable

Currently in the Pharma industry, data is largely siloed and non-interoperable. OpenPharma is working to change this, making data de-siloed and interoperable, maintaining industry standards across the board and providing quick and secure data pipelines.

Learn More
Open Pharma Application icon
Real-Time

Near real-time data exchange allows for better collaboration, allows users to quickly gain insight to develop a deeper understanding, which in turn allows for quick action

Learn More
Open Pharma documentation icon
Consumer Grade

We carefully enforce our design standards in our interfaces to maintain consistency and familiarity for flexibility and efficiency of use for an excellent consumer grade user experience

Learn More

Modern APIs for a Progressive Life Science Landscape

At OpenPharma we believe that true innovation involves open dialog; clear communication requires mutual understanding, whether human-to-human or machine-to-machine. Our APIs are built to for flawless interoperability thus allowing the free exchange of information and ideas.

Join a community of life science interoperability.

The OpenPharma platform was engineered with you in mind. Imagine having the ability to make major leaps forward in your work and being able to share your ideas with colleagues immediately without the pain of third party applications. This is reality using OpenPharma.

APIs
Logo

Get To Know Us

Take a look at the projects we are tackling in the life sciences industry.

OpenPharma at a Glance - Patient's Perspective

Overview of OpenPharma core concepts, from patient perspective.

OpenPharma at a Glance - Under the Hood

Brief overview of what's under the hood of OpenPharma.

Hedera Hashgraph

The Hedera hashgraph platform provides a new form of distributed consensus; a way for people who don't know or trust each other to securely collaborate and transact online without the need for a trusted intermediary.

Logo

Join a community of life science interoperability.

"We're excited to see Certara be one of the very first implementations of a Hedera mirror node, to provide reporting and analytics for transactions on the Hedera network, particularly for healthcare and supply chain use cases," said Mance Harmon, Co-founder and CEO of Hedera. "We are committed to working alongside Certara on the pioneering work they're doing around OpenPharma, and realizing the potential of distributed technology for the healthcare industry to deliver improved outcomes and lower cost for patients."

Hedera Hashgraph

Utilizing the Technology

hasharc is a new generation of blockchain explorer implemented for the ledger Hedera Hashgraph platform.

Transaction Insights Simplified

We're excited to see Certara be one of the very first implementations of a Hedera mirror node, to provide reporting and analytics for transactions on the Hedera network, particularly for healthcare and supply chain use cases,” said Mance Harmon, Co-founder and CEO of Hedera. “We are committed to working alongside Certara on the pioneering work they're doing around OpenPharma, and realizing the potential of distributed technology for the healthcare industry to deliver improved outcomes and lower cost for patients

hasharc
Logo
Logo

Transaction Insights Simplified

We're excited to see Certara be one of the very first implementations of a Hedera mirror node, to provide reporting and analytics for transactions on the Hedera network, particularly for healthcare and supply chain use cases,” said Mance Harmon, Co-founder and CEO of Hedera. “We are committed to working alongside Certara on the pioneering work they're doing around OpenPharma, and realizing the potential of distributed technology for the healthcare industry to deliver improved outcomes and lower cost for patients

Hasharc

What people say about OpenPharma:

Marsali Hancock CEO & President of EP3 Foundation
Marsali Hancock CEO & President of EP3 Foundation

Open Pharma increases patients' and providers' access to privacy protected data. Information fuels innovation. It empowers individuals with new opportunities and insights to improve health and wellness outcomes. EP3 Foundation welcomes every effort to liberate privacy protected data previously locked in silos.

Marsali Hancock CEO & President of EP3 Foundation
Dr. John Sviokla Consultant and former Harvard Business School Professor

Knowledge creation is the core of any advancement in healthcare in general and Pharma in particular.  A robust, open platform is essential in speeding up human understandings of health and disease and this is a great new step in that direction.

Marsali Hancock CEO & President of EP3 Foundation
Brad Perkins, MD Co-Founder and CEO. Sapiens Data Science, Inc.

This is a critically important effort which will accelerate science and advance health.  We look forward to participating with others on this exciting new platform and congratulate the leaders who have taken this bold step into the future.

Marsali Hancock CEO & President of EP3 Foundation
Joshua C. Rubin, JD, MBA, MPH, MPP EP3 Foundation Policy Fellow

Democratizing health together is a moral imperative of our time. Open APIs hold the potential to empower researchers, clinicians, and patients; they engender transparency and fuel collaborative innovation across pharma and life sciences to ultimately improve the health of individuals, families, communities, populations, and the general public.

Marsali Hancock CEO & President of EP3 Foundation
Jesse O’Gorman Executive Director & COO, Parallel6

Open standards and a strong community are critical to interoperability and enabling advanced clinical research. The OpenPharma platform and developer community is positioned to make a significant impact on the access, usability of and value of health data. We look forward to contributing and working with the OpenPharma community.

Marsali Hancock CEO & President of EP3 Foundation
Teri Schroeder Chief Executive Officer. ISafe Ventures.

Open technology and open API’s has a lot of value in today’s global environment. For the protection of all consumers it is imperative to deploy high assurance, standards based identity credentials when accessing sensitive data.

Marsali Hancock CEO & President of EP3 Foundation
Jonathan Hare CEO and Co-Founder WebShield Inc.

We believe open technology, open APIs are the way to go to address the decades long technology interoperability and innovation issues in life sciences. OpenPharma is a great step forward in this direction.